巴基斯坦炼油厂2024财年利润激增123%
Company announces final cash dividend of Rs2 per share Driven by a significant increase in revenue, Pakistan Refinery Limited (PRL), a subsidiary of the Pakistan State Oil Company Limited (PSO),…
作者
全球丝绸之路研究联盟创始人兼主席
Zamir Ahmed Awan is the founder and Chair of the Global Silk Route Research Alliance,
a think tank in Islamabad.
He studied engineering at Shanghai University in the 1980s, and years later he went
back to China as Pakistan's science counsellor in Beijing, from 2010 until 2016,
working on science and higher education cooperation between the two countries. When
he came home he set up the China Study Centre at NUST. He retired from there.
He writes about CPEC and the Belt and Road, and about what China's rise means for
Pakistan. His articles run in Modern Diplomacy and on Think Tank Pakistan, and China
Daily and China News Service have both quoted the work.
本作者有 11,534 篇
Company announces final cash dividend of Rs2 per share Driven by a significant increase in revenue, Pakistan Refinery Limited (PRL), a subsidiary of the Pakistan State Oil Company Limited (PSO),…
Participants of a cross-strait journalism camp visit the China National Archives of Publications and Culture (CNAPC) in Beijing, capital of China, Aug. 24, 2024. A cross-strait journalism camp for university…
Dynea Pakistan Limited (PSX: DYNO) was incorporated in Pakistan as a public limited company in 1982. The principal activity of the company is the manufacturing and sale of formaldehyde, urea/melamine…
China's Office of the Central Cyberspace Affairs Commission and nine central departments have issued new guidelines for the coordinated transformation toward digital development and green growth. Published on Saturday, the…
Peugeot is rumored to be gearing up for a significant entry into the Pakistani market with the launch of potentially multiple new models in 2025, as per our intel. Following…
With the help of Insilico Medicine's research and development team in Shanghai, the globally leading AI-driven biotech company has condensed preclinical drug development from multiple years into just 18 months.…



